Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on December 9, 2011. The filing serves as a Regulation FD disclosure regarding upcoming communications between company officers and securities analysts/investors scheduled between December 9, 2011, and December 23, 2011.
Key Financial Metrics
The filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity figures for the period. The only specific financial metric disclosed is the reaffirmed earnings per share (EPS) guidance for the full year 2011.
- Full Year 2011 EPS Guidance: $7.18 to $7.28 per share.
- Net Investment Gains Included: $0.28 per share.
- Investment Outlook: The guidance assumes no additional investment gains or losses beyond those recorded in the first three quarters of 2011.
Material Changes
The filing does not report material changes to financial results, operations, or corporate structure compared to prior periods. It solely confirms the continuation of previously issued earnings guidance.
Guidance, Outlook, and Risks
Management Commentary: Officers expect to reaffirm the full-year 2011 EPS range during the specified analyst meetings. The company explicitly states that the outlook includes no further investment gains or losses.
Risks and Contingencies: The filing includes a comprehensive Safe Harbor statement identifying numerous risks that could cause actual results to differ from projections, including:
- Impact of the Patient Protection and Affordable Care Act and related regulations.
- Trends in health care costs, utilization rates, and premium rate approvals.
- Competitor pricing and changes in product mix or enrollment.
- Risks related to Medicare and Medicaid programs, including funding and compliance.
- Financial strength rating downgrades and litigation risks.
- Non-compliance with the Express Scripts, Inc. pharmacy benefit management agreement.
- Information system failures and data security breaches.
- Impairment of intangible assets and goodwill.
- General economic downturns and investment portfolio volatility.
Investor Verification Checklist
- Verify the actual full-year 2011 EPS against the reaffirmed range of $7.18 to $7.28.
- Confirm that net investment gains for the fourth quarter remained consistent with the $0.28 per share assumption (i.e., no significant new gains or losses).
- Review subsequent filings for updates on the Express Scripts agreement compliance status.
- Monitor regulatory developments regarding the Affordable Care Act and their impact on premium rates and enrollment.